(Date:1/8/2009)...ions offers five action steps to improve response ...-- Despite the recent three-hour cease fires to al...esidents of the Palestinian territory, upwards of ...ter and medical help. U.S.-based international hum...see this arrangement to allow sporadic delivery of...
(Date:1/8/2009)... of cancer cells are keys to the development of a ...e spread of certain types of cancers called carcin...lung, among others. Armed with a new two-year gra...ch, an Illinois-based philanthropic foundation, im... co-workers at the Moores Cancer Center at the Uni...
(Date:1/8/2009)... at his confirmation hearing to be the next Secret...GTON, Jan. 8 Bipartisan... Tom Daschle, nominee for Department of Health and...w BPC founder and friend Senator Bob Dole at his c...d by the Senate Health, Education, Labor, and Pens...
(Date:1/8/2009)...ctor in Decision for Florida Multi-Specialty Group...wire-FirstCall/ -- Allscripts announced today that...i-specialty group practices in the Southeast Unite...M) Electronic Health Record (EHR) to automate and ...entral Florida. , , (Logo: http://www.newsco...
Breaking Medicine News(10 mins):Health News:Temporary Cease Fires Not Enough for Humanitarian Aid Groups Working in Gaza 2Health News:Temporary Cease Fires Not Enough for Humanitarian Aid Groups Working in Gaza 3Health News:Novel prostate cancer vaccine taking aim at cancer cell 'sweet spot' 2Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 2Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 3Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 4Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 3Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 4...uire better memories, literacy skills and math ski...y was conducted by// Laurel Trainor, professor of ...University in Hamilton, Ontario and her team. The... aged 4-6. They took a music test after attending ...
... a pack-a-day crisp habit is prevalent among 55% o...alent of five litres of// cooking oil annually. T...g people about the amount of hidden salt, fat and ...were releases as a part of it. 'I am concerned we ...
...d Journal of Medicine says that stem cells may not...h is needed to ascertain// these findings. Three ...o survivors of heart attacks and found that these ...maged hearts. Researchers looked at whether stem c...
...t is considering introducing a needle exchange pro...king can trigger// diseases like Hepatitis C and H...y have shared needles in prison. There will always...in prison," a SPS spokesman told BBC. "If you're n...
Other Medicine News:(Date:1/6/2009)...ry 6 , - Early Re... Until,December 2011 , - Expansion of the ...scovery in Ophthalmology , - Revised Commer...blicenses to a Third Party , ExonHit Ther...forcement,of its existing drug discovery collabor...
(Date:1/5/2009)...5 Micromet, Inc.,(Nasda...g novel, proprietary,antibodies for the treatment...,provides an outlook on key events anticipated for...vide an update on its research and development,pr...12 to 16, 2009: Update on several preclinical BiTE...
(Date:1/3/2009)... , ROSEMONT, Ill., Jan. 2 /PRNewswire-USNewswire/...technology providing an increasing number of clini...ain according to an article in the January 2009 is...opaedic Surgeons ( http://www.jaaos.org/ ). It is...ional technical developments will allow MRI to pro...
(Date:12/29/2008)...PRNewswire-USNewswire/ -- The winner of the 2008 A...as announced today by Dr. Peter G. Goldschmidt, Pr...itute. , , The winner of the annual award was ...enter -- for its best practice " IND Regulatory ...r 1) enhanced human subjects protection, 2) improv...
Breaking Medicine Technology:ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5MRI Emerges As Vital Resource in Treatment of Back Pain 2MRI Emerges As Vital Resource in Treatment of Back Pain 32008 Human Research Protection Award Recipients Announced 2Hospice Programs Nationwide Urge Congress to Act on Behalf of End of Life Patients 22308 1Hospice Programs Nationwide Urge Congress to Act on Behalf of End of Life Patients 22308 2Dilon Technologies Announces National Agreement with MedAssets 22306 1Dilon Technologies Announces National Agreement with MedAssets 22306 2Quintiles Appoints New Executives 6110 1Quintiles Appoints New Executives 6110 2New findings on immune system in amphibians 3703 1New findings on immune system in amphibians 3703 2... Phase III Study Provides Further Evidence of,the ...e Treatment,of Rheumatoid Arthritis, BASEL, Switze...ard (1), the second multinational phase III Actemr...imary endpoint and,showed that a greater proportio...with traditional disease modifying drugs (DMARDs),...
...nd Pharmacokinetics Similar to IV Doses in,Phase 3.../PRNewswire-FirstCall/ --,Genta Incorporated annou...ts that show the Company,s lead anti-cancer drug,... safely,administered by intermittent subcutaneous ...V) infusion. These regimens may,eventually reduce ...
Other Medicine Technology:New Data Confirms Significant Improvement of Disease Signs and,Symptoms in Patients with Rheumatoid Arthritis 2New Data Confirms Significant Improvement of Disease Signs and,Symptoms in Patients with Rheumatoid Arthritis 3New Data Confirms Significant Improvement of Disease Signs and,Symptoms in Patients with Rheumatoid Arthritis 4Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 2Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 3Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 4A rapid rise in intracranial pressure requires early recognition, intervention and continuous monitoring. Ventrix utilizes state-of-the-art fiberoptic technology that gets to the source of pressure.
The MPM-1 offers a broad range of functions to attain new levels of parenchymal and ventricular monitoring through fiberoptic technology at the source.
The Codman ICP Monitoring System provides highly accurate measurements of intracranial pressure at the source-subdural, parenchymal or intraventricular levels. The information is relayed electronical
The Polaris system delivers the most innovative optical tracking technology. Compact, cost effective and easy to use, this unique system combines the highest level of precision measurement with unpre
Medicine Products: